BODY MASS INDEX AND BEVACIZUMAB IN FIRST LINE TREATMENT FOR ADVANCED OVARIAN CANCER (AOC)

2016 ◽  
Author(s):  
Ida Paris
Keyword(s):  
Ovarian Cancer ◽  
Body Mass Index ◽  
Body Mass ◽  
Advanced Ovarian Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Sequential gemcitabine–carboplatin followed by paclitaxel–carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study

2006 ◽  
Vol 101 (1) ◽  
pp. 114-119 ◽  
Author(s):  
Johanna U. Mäenpää ◽  
Seija E. Grénman ◽  
Jyrki T. Jalkanen ◽  
Tapio A. Kuoppala ◽  
Arto O. Leminen ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Ovarian Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

2019 ◽  
Vol 20 (6) ◽  
pp. 862-876 ◽  
Author(s):  
Ignace Vergote ◽  
Giovanni Scambia ◽  
David M O'Malley ◽  
Ben Van Calster ◽  
Sang-Yoon Park ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Advanced Ovarian Cancer ◽  
Line Treatment ◽  
First Line ◽  
Phase 3 ◽  
Double Blind ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document